Increased pressor sensitivity to chronic nitric oxide deficiency in hyperthyroid rats

Hypertension

Volumn 42, Issue 2, 2003, Pages 220-225

  Rodríguez Gómez, Isabel ^a   Sainz, Juan ^a   Wangensteen, Rosemary ^a   Moreno, Juan Manuel ^a   Duarte, Juan ^b   Osuna, Antonio ^c   Vargas, Félix ^a  

^a UNIVERSITY OF GRANADA   (Spain)

^b Facultad de Farmacia   (Spain)

^c NONE

Author keywords

Blood pressure; Hyperthyroidism; Hypertrophy, cardiac; Losartan; Nitric oxide

Indexed keywords

ANGIOTENSIN; LOSARTAN; N(G) NITROARGININE METHYL ESTER; NITRATE; NITRIC OXIDE; NITRITE; THYROXINE; ANGIOTENSIN II; CREATININE; ENZYME INHIBITOR; NITRIC OXIDE SYNTHASE; POTASSIUM; SODIUM;

ANGIOTENSIN BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD LEVEL; BLOOD PRESSURE REGULATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CREATININE CLEARANCE; DRUG EFFECT; HEART RATE; HYPERTHYROIDISM; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; POTASSIUM EXCRETION; PRIORITY JOURNAL; RAT; SODIUM EXCRETION; SYSTOLIC BLOOD PRESSURE; TAIL; URINE FLOW RATE; ANIMAL; BLOOD; BLOOD PRESSURE; CHEMICALLY INDUCED DISORDER; DRUG ANTAGONISM; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; PROTEINURIA; URINE; WISTAR RAT;

ANGIOTENSIN II; ANIMALS; BLOOD PRESSURE; CREATININE; ENZYME INHIBITORS; HEART RATE; HYPERTHYROIDISM; LOSARTAN; MALE; NG-NITROARGININE METHYL ESTER; NITRATES; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRITES; POTASSIUM; PROTEINURIA; RATS; RATS, WISTAR; SODIUM; THYROXINE;

EID: 0041765643     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.0000081944.47230.69     Document Type: Article

References (37)

1. Larsen PR, Davis TF, Hay ID. The thyroid gland. In: Wilson JD, Foster DW, Kronenberg HK, Larsen PR, eds. Williams Textbook of Endocrinology. 6th ed. London, England: WB Saunders Co; 1998:389-515.
2. Bradley SE, Stephan F, Coelho JB, Reville P. The thyroid and the kidney. Kidney Int. 1974;6:346-365.
3. Klein I. Thyroid hormone and the cardiovascular system. Am J Med. 1990;88:631-637.
4. Klein I, Ojamaa K. Thyroid hormone and blood pressure regulation. In: Laragh JH, Brenner BN, eds. Hypertension: Pathophysiology, Diagnosis and Management. 2nd ed. New York, NY: Raven Press Ltd; 1995:2247-2262.
5. Vargas F, Baz MJ, Luna JD, Andrade J, Jodar E, Haro JM. Urinary excretion of digoxin-like immunoreactive factor and arginine vasopressin in hyper- and hypothyroid rats. Clin Sci. 1991;81:471-476.
6. Vargas F, Atucha N, Sabio JM, Quesada T, García-Estañ J. Pressure-diuresis-natriuresis response in hyper- and hypothyroid rats. Clin Sci. 1994;87:323-328.
7. Gardiner SM, Compton AM, Bennett T, Palmer RMJ, Moncada S. Control of regional blood flow by endothelium-derived nitric oxide. Hypertension. 1990;15:486-492.
8. Romero JC, Lahera V, Salom MG, Biondi ML. Role of the endothelium-dependent relaxing factor nitric oxide on renal function. J Am Soc Nephrol. 1992;2:1371-1387.
9. Cowley AW, Mattson DL, Lu S, Roman RJ. The renal medulla and hypertension. Hypertension. 1995;25:663-673.
10. Moncada S, Palmer RMJ, Higgs EA. Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol Rev. 1991;43:109-142.
11. Zatz R, Baylis C. Chronic nitric oxide inhibition model 6 years on. Hypertension. 1998;32:958-964.
12. Fernández-Rivas A, García-Estañ J, Vargas F. Effects of chronic increased salt intake on nitric oxide synthesis inhibition-induced hypertension. J Hypertens. 1995;13:123-128.
13. Vargas F, Fernández-Rivas A, García-Estañ J, García del Río C. Endothelium-dependent and endothelium-independent vasodilation in hyper-thyroid and hypothyroid rats. Pharmacology. 1995;51:308-314.
14. Fernández V, Cornejo P, Tapia G, Videla LA. Influence of hyperthyroidism on the activity of liver nitric. Nitric Oxide. 1997;1:143-148.
15. Quesada A, Sainz J, Wangensteen R, Rodríguez-Gómez I, Vargas F, Osuna A. Nitric oxide synthase activity in hyperthyroid and hypothyroid rats. Eur J Endocrinol. 2002;147:1-6.
16. Ganong WF. Thyroid hormones and renin secretion. Life Sci. 1982;30:577-584.
17. Jiménez E, Montiel M, Narváez JA, Morel M. Effects of hyper and hypothyroidism on the basal levels of angiotensin I and kinetic parameters of renin angiotensin system in male rats. Rev Esp Fisiol. 1982;38:149-154.
18. García del Río C, Moreno MRR, Osuna A, Luna JD, García-Estañ J, Vargas F. Role of the renin-angiotensin system in the development of thyroxine-induced hypertension. Eur J Endocrinol. 1997;136:656- 660.
19. García-Estañ J, Atucha N, Quesada T, Vargas F. Involvement of the renin-angiotensin in the reduced pressure-natriuresis response of hyper-thyroid rats. Am J Physiol. 1995;268:E897-E901.
20. Ribeiro MO, Antunes E, de Nucci G, Lovisolo SM, Zatz R. Chronic inhibition of nitric oxide synthesis: a new model of arterial hypertension. Hypertension. 1992;20:298-303.
21. De Gracia MC, Osuna A, O'Valle F, Del Moral RG, Wangensteen R, García del Río C, Vargas F. Deoxycorticosterone suppresses the effects of losartan in nitric oxide-deficient hypertensive rats. J Am Soc Nephrol. 2000;11:1995-2000.
22. Raij L. Hypertension and cardiovascular risk factors: role of the angiotensin II-nitric oxide interaction. Hypertension. 2001;37:767-773.
23. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976;72:248-254.
24. Granger DL, Taintor RR, Boockvar KS, Hibbs JB. Measurement of nitrate and nitrite in biochemical samples using nitrate reductase and Griess reaction. Method Enzymol. 1996;268:142-151.
25. Ni Z, Morcos S, Vaziri ND. Up-regulation of renal and vascular nitric oxide synthase in iron-deficiency anaemia. Kidney Int. 1997;52:195-201.
26. Martin PY, Xu DL, Niederberger M, Weigert A, Tsai P, St John J, Gines P, Schrier RW. Upregulation of endothelial constitutive NOS: a major role in the increased NO production in cirrhotic rats. Am J Physiol. 1996;270:F494-F499.
27. Romero JC, García-Estañ J, Atucha NM. The role of nitric oxide on renal function: the control of blood pressure under normal conditions and during cirrhosis. In: Epstein M, ed. The Kidney in Liver Disease. 4th ed. Philadelphia, Pa: Hanley & Belfus Inc; 1996:373-385.
28. Millatt LJ, Abdel-Rahman EM, Siragy HM. Angiotensin II and nitric oxide: a question of balance. Regul Pept. 1999;81:1-10.
29. Vargas F, Osuna A. Modulatory role of endothelium derived relaxing factors on the response to vasoconstrictors and flow-pressure curve in the isolated perfused rat kidney. J Vasc Res. 1996;33:119-123.
30. Honda H, Iwata T, Mochizuki T, Kogo H. Changes in vascular reactivity induced by acute hyperthyroidism in isolated rat aorta. Gen Pharmacol. 2000;34:429-434.
31. Kobori H, Ichihara A, Miyashita Y, Hayashi M, Saruta T. Local renin-angiotensin system contributes to hyperthyroidism-induced cardiac hypertrophy. J Endocrinol. 1999;160:43-47.
32. Kobori H, Ichihara A, Suzuki H, Takenaka T, Miyashita Y, Hayashi M, Saruta T. Role of the renin-angiotensin system in cardiac hypertrophy induced in rats by hyperthyroidism. Am J Physiol. 1997;273:H593-H599.
33. Bedotto JB, Gay RG, Graham SD, Morkin E, Goldman S. Cardiac hypertrophy induced by thyroid hormone is independent of loading conditions and β-adrenoceptor blockade. J Pharmacol Exp Ther. 1989;248:632-636.
34. Morgan HE, Baker KM. Cardiac hypertrophy: mechanical, neural, and endocrine dependence. Circulation. 1991;83:13-25.
35. Weetman AP, Tomlinson K, Amos N, Lazarus JH, Hall R, McGregor AM. Proteinuria in autoimmune thyroid disease. Acta Endocrinol (Copenh). 1985;109:341-347.
36. Li B, Yao J, Morioka T, Oite T. Nitric oxide increases albumin permeability of isolated rat glomeruli via a phosphorylation-dependent mechanism. J Am Soc Nephrol. 2001;12:2616-2624.
37. Tanwani LK, Lohano V, Broadstone VL, Mokshagundam SP. Minimal change nephropathy and Graves' disease: report of a case and review of the literature. Endocr Pract. 2002;8:40-43.